DNAprint Genomics (DNAG)

[High_Hopes]

Statin Research - Has this been posted yet?

Found this on page 8 of a post polio support group's newsletter

http://www.postpoliosupport.com/polio%20post%20news.htm

DNAPrint genomics and the Research Project

Carolyn Raville has been in touch with Tony Frudakis, PhD., president, CEO and Laboratory Director at the Sarasota-based firm DNAPrint genomics. Dr. Frudakis, a molecular biologist, would like to conduct a research project with our members who have experienced statin-related muscle pain to see whether a genetic trait exists that causes some people to be especially susceptible to the muscle-related side effects of statin drugs. If the genetic trait can be identified, DNAPrint genomics will proceed in developing a test that may be used prior to statin use.

The research test procedure will involve no blood sampling but only the collection of a tissue sample by a cotton swab (painless!) from the inside of your cheek. The sample will be collected in a confidential manner and only used for the "statin collection project."

We plan on working with DNAPrint genomics to conduct the research at the October 12th North Central Post-Polio Support Group meeting. Look for more news next month in Polio Post News on this exciting opportunity to be part of a ground-breaking solution to avoiding statin side effects!

To learn more about DNAprint genomics, check out their web-site at www.dnaprint.com and click on Programs and then click on Statins.

Written by Carol Bohach, BS Pharm, a 1949 polio survivor and an independent Clinical Research Consultant who lives in Land O’Lakes, FL. She cannot take statin drugs due to muscle-related side effects.